Related Experiment Videos
Development of a rapid chemosensitivity test for anticancer drugs with contact-sensitive monolayers of Balb/3T3 cells
1First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Abstract:
We investigated whether lethally irradiated, contact-sensitive Balb/3T3 cell confluent monolayers, termed "cell mats," could be used for the screening of human tumors for sensitivity to anticancer drugs. Cell mats greatly inhibited the growth of normal Balb/3T3 cells and normal human fibroblasts but did not inhibit the growth of human tumor cells. To assess chemosensitivity of tumor cells, we measured the [14C]thymidine (dThd) incorporation by tumor cells that had been plated and then treated with various anticancer drugs on the cell mats. Although the [14C]dThd incorporation assay, when compared with the colony-formation assay, underestimated the toxicity of certain drugs, the assays gave similar results with regard to the degree of colony inhibition and to the decrease in [14C]dThd incorporation when various anticancer drugs were used at the same concentration ranges. Therefore, the method we used for measuring the isotope uptake in the cell mats could also be used to test for tumor-specific chemosensitivity. Because our results from this assay on various human tumor cells, including those from primary human tumors, can be obtained within 5 days, we believe that the system is potentially useful for testing anticancer drugs against human tumors in vitro.
Insights
This study shows that "cell mats" can screen human tumors for anticancer drug sensitivity. This method, using [14C]thymidine incorporation, provides rapid results for tumor-specific chemosensitivity testing in vitro.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Accurate prediction of anticancer drug efficacy is crucial for personalized cancer treatment.
- Existing chemosensitivity assays can be time-consuming and complex.
- Development of rapid and reliable in vitro screening methods is needed.
Purpose of the Study:
- To evaluate the utility of lethally irradiated Balb/3T3 cell confluent monolayers ("cell mats") for screening human tumor chemosensitivity.
- To assess the feasibility of using [14C]thymidine incorporation as a measure of tumor cell drug response on cell mats.
- To determine the potential of this system for rapid, in vitro anticancer drug testing.
Main Methods:
- Establishment of "cell mats" using lethally irradiated, contact-sensitive Balb/3T3 cells.
- Culturing human tumor cells on cell mats and exposing them to various anticancer drugs.
- Quantification of [14C]thymidine incorporation by tumor cells as an indicator of drug sensitivity.
- Comparison of results with traditional colony-formation assays.
Main Results:
- Cell mats effectively inhibited normal cell growth while allowing tumor cell proliferation.
- [14C]thymidine incorporation assay showed comparable results to colony-formation assays for drug efficacy.
- The assay demonstrated tumor-specific chemosensitivity across various human tumor types, including primary tumors.
- Results were obtainable within 5 days, indicating a rapid screening capability.
Conclusions:
- The cell mat system, coupled with [14C]thymidine incorporation, is a viable method for in vitro screening of human tumor chemosensitivity.
- This approach offers a potentially faster and effective alternative for predicting anticancer drug response.
- The system holds promise for guiding clinical decisions in cancer therapy by providing timely drug sensitivity data.